This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
"Demographic details of all patients (22-year-old man, 41-year old woman, 61-year-old woman and 33-year-old woman) were obtained through personal communication with the author."
Zilioli VR, et al. Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin's lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: A single-center real-life experience. International Journal of Hematologic Oncology 9: 286, No. 1, Mar 2020. Available from: URL: http://doi.org/10.2217/ijh-2020-0001
About this article
Cite this article
Antineoplastics/methylprednisolone/netupitant/palonosetron. Reactions Weekly 1809, 45 (2020). https://doi.org/10.1007/s40278-020-79829-6